New knee injection shows promise for arthritis pain relief

NCT ID NCT06263270

Completed Symptom relief Sponsor: Cytonics Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested the safety of an experimental drug called CYT-108 for people with mild to moderate knee osteoarthritis. Nineteen participants received either the drug or a placebo injection into the knee, and researchers monitored them for 26 weeks. The goal was to see if the drug is safe and if it might reduce pain and stiffness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arthralgia arthritic joint disease osteoarthritis osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OSTEOARTHRITIS OSTEOARTHRITIS, KNEE

Contacts and locations

Locations

Emeritus Research

Camberwell, Victoria, 3124, Australia
Novatrials

Kotara, New South Wales, 2289, Australia
University of Sunshine Coast Clinical Trials

Sunshine Coast, Birtinya QLD, 4575, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.